Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Temozolomide/topotecan/trametinib

Various toxicities: case report

    This is a preview of subscription content, log in to check access.

    Reference

    1. Farnault L, et al. Response to trametinib of histiocytosis with an activating PTPN11 mutation. Leukemia and Lymphoma 61: 194-197, No. 1, 2020. Available from: URL: http://doi.org/10.1080/10428194.2019.1650175

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Temozolomide/topotecan/trametinib. Reactions Weekly 1790, 210 (2020). https://doi.org/10.1007/s40278-020-74828-8

    Download citation